VANCOMYCIN

VANCOMYCIN was reported 58338 times

VANCOMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VANCOMYCIN INFUSION REACTION 217 0.5756
1 RED MAN SYNDROME 393 0.4466
2 LINEAR IGA DISEASE 595 0.3574
3 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 139 0.3424
4 GEOTRICHUM INFECTION 61 0.2891
5 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 77 0.2492
6 CHOROIDITIS 67 0.1791
7 TRICHOSPORON INFECTION 58 0.1432
8 RETINAL VASCULITIS 160 0.1343
9 DISSEMINATED MUCORMYCOSIS 51 0.1294
10 RHINOCEREBRAL MUCORMYCOSIS 42 0.1210
11 FUNGAL ENDOCARDITIS 35 0.1163
12 CARDIAC VALVE VEGETATION 51 0.1049
13 FUNGAEMIA 160 0.1016
14 ACINETOBACTER INFECTION 109 0.0995
15 ENTEROCOCCUS TEST POSITIVE 64 0.0988
16 BACTERIAL DISEASE CARRIER 71 0.0974
17 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2411 0.0936
18 DYSBIOSIS 72 0.0877
19 STENOTROPHOMONAS INFECTION 117 0.0862
20 SYSTEMIC CANDIDA 214 0.0852
21 SEPTIC EMBOLUS 69 0.0829
22 RENAL TUBULAR NECROSIS 809 0.0824
23 FUSARIUM INFECTION 56 0.0800
24 SEPSIS SYNDROME 40 0.0797
25 ENTEROCOCCAL INFECTION 378 0.0781
26 NEPHROPATHY TOXIC 845 0.0752
27 CLOSTRIDIUM TEST POSITIVE 165 0.0748
28 RASH MORBILLIFORM 192 0.0692
29 ENTEROCOCCAL SEPSIS 55 0.0679
30 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 219 0.0674
31 CORYNEBACTERIUM INFECTION 36 0.0673
32 PSEUDOMEMBRANOUS COLITIS 149 0.0667
33 CRYSTAL NEPHROPATHY 39 0.0659
34 MEGACOLON 100 0.0636
35 ENTEROCOCCAL BACTERAEMIA 67 0.0632
36 CLOSTRIDIUM DIFFICILE COLITIS 669 0.0630
37 STAPHYLOCOCCAL BACTERAEMIA 271 0.0623
38 PSEUDOMONAL BACTERAEMIA 53 0.0621
39 PNEUMONIA NECROTISING 40 0.0618
40 CLOSTRIDIUM DIFFICILE INFECTION 1328 0.0608
41 DEVICE RELATED SEPSIS 120 0.0596
42 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 458 0.0589
43 OTOTOXICITY 108 0.0583
44 BRONCHIAL SECRETION RETENTION 74 0.0581
45 BACILLUS INFECTION 36 0.0570
46 PATHOGEN RESISTANCE 514 0.0563
47 TOXIC ANTERIOR SEGMENT SYNDROME 61 0.0559
48 RETINAL VASCULAR OCCLUSION 41 0.0554
49 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 58 0.0546
50 MUCORMYCOSIS 141 0.0542
51 APLASTIC ANAEMIA 278 0.0532
52 NEPHRITIS INTERSTITIAL 67 0.0530
53 CLOSTRIDIUM COLITIS 64 0.0527
54 SUPERINFECTION 79 0.0526
55 EOSINOPHILIC PNEUMONIA ACUTE 45 0.0520
56 FUNGAL SEPSIS 43 0.0517
57 KLEBSIELLA INFECTION 260 0.0514
58 TOXIC EPIDERMAL NECROLYSIS 762 0.0501
59 CANDIDA SEPSIS 44 0.0491
60 PROCALCITONIN INCREASED 57 0.0486
61 EOSINOPHILIA 834 0.0475
62 ENDOCARDITIS 240 0.0467
63 RENAL TUBULAR INJURY 56 0.0461
64 PSEUDOMONAS TEST POSITIVE 37 0.0452
65 PNEUMONIA STAPHYLOCOCCAL 89 0.0451
66 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 37 0.0450
67 SYSTEMIC MYCOSIS 51 0.0437
68 CONTINUOUS HAEMODIAFILTRATION 42 0.0429
69 MULTI-ORGAN FAILURE 742 0.0429
70 STAPHYLOCOCCUS TEST POSITIVE 90 0.0427
71 BRAIN ABSCESS 108 0.0426
72 ENTEROBACTER INFECTION 71 0.0422
73 TYPE IV HYPERSENSITIVITY REACTION 115 0.0419
74 HYPOPERFUSION 44 0.0418
75 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1172 0.0413
76 HISTIOCYTOSIS HAEMATOPHAGIC 120 0.0404
77 TUBULOINTERSTITIAL NEPHRITIS 741 0.0395
78 BACTERAEMIA 464 0.0391
79 MULTIPLE-DRUG RESISTANCE 121 0.0390
80 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 149 0.0390
81 STREPTOCOCCAL BACTERAEMIA 42 0.0386
82 NEPHROGENIC ANAEMIA 178 0.0384
83 STRONGYLOIDIASIS 62 0.0383
84 STAPHYLOCOCCAL SEPSIS 187 0.0378
85 ENDOPHTHALMITIS 227 0.0378
86 MENINGITIS BACTERIAL 54 0.0377
87 HAEMODYNAMIC INSTABILITY 287 0.0376
88 SEPTIC SHOCK 1638 0.0376
89 VASCULAR DEVICE INFECTION 170 0.0374
90 PNEUMONIA KLEBSIELLA 68 0.0370
91 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 34 0.0368
92 BLOOD CULTURE POSITIVE 107 0.0357
93 CLOSTRIDIAL INFECTION 119 0.0351
94 ASPERGILLUS INFECTION 227 0.0346
95 ASPERGILLOSIS 45 0.0344
96 DRUG LEVEL INCREASED 562 0.0339
97 NECROTISING COLITIS 43 0.0339
98 APLASIA 66 0.0337
99 HYPERPARATHYROIDISM SECONDARY 83 0.0331
100 PSEUDOMONAS INFECTION 284 0.0331
101 INTERVERTEBRAL DISCITIS 62 0.0329
102 RASH MACULO-PAPULAR 730 0.0328
103 HUMAN HERPESVIRUS 6 INFECTION 62 0.0328
104 BRONCHOPULMONARY ASPERGILLOSIS 253 0.0326
105 NEUTROPENIC COLITIS 67 0.0324
106 OLIGURIA 201 0.0323
107 BACTERIAL SEPSIS 104 0.0319
108 KOUNIS SYNDROME 72 0.0317
109 VENOOCCLUSIVE LIVER DISEASE 156 0.0316
110 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 237 0.0315
111 DIFFUSE ALVEOLAR DAMAGE 36 0.0313
112 NECROTISING FASCIITIS 109 0.0309
113 HISTOPLASMOSIS DISSEMINATED 49 0.0309
114 PNEUMONIA FUNGAL 120 0.0304
115 RENAL TUBULAR DISORDER 85 0.0302
116 DISSEMINATED INTRAVASCULAR COAGULATION 419 0.0297
117 PSEUDOMONAL SEPSIS 52 0.0297
118 EMPYEMA 59 0.0296
119 ACUTE KIDNEY INJURY 4422 0.0289
120 DRUG LEVEL ABOVE THERAPEUTIC 130 0.0284
121 ATELECTASIS 271 0.0280
122 HENOCH-SCHONLEIN PURPURA 61 0.0279
123 STAPHYLOCOCCAL INFECTION 919 0.0278
124 LIVER ABSCESS 90 0.0277
125 ACUTE RESPIRATORY DISTRESS SYNDROME 489 0.0276
126 CRYPTOCOCCOSIS 45 0.0276
127 DRUG CLEARANCE DECREASED 36 0.0275
128 DIABETES INSIPIDUS 66 0.0274
129 HEPARIN-INDUCED THROMBOCYTOPENIA 135 0.0274
130 EOSINOPHILIC PNEUMONIA 86 0.0273
131 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 58 0.0272
132 LEUKOCYTOSIS 491 0.0271
133 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 72 0.0270
134 DERMATITIS EXFOLIATIVE GENERALISED 94 0.0270
135 DRUG RESISTANCE 685 0.0266
136 HAEMODIALYSIS 222 0.0264
137 CULTURE URINE POSITIVE 37 0.0263
138 FUNGAL PERITONITIS 40 0.0263
139 ISCHAEMIC HEPATITIS 36 0.0263
140 IMMUNE THROMBOCYTOPENIA 120 0.0262
141 WOUND INFECTION STAPHYLOCOCCAL 45 0.0260
142 NOCARDIOSIS 66 0.0258
143 GRAFT VERSUS HOST DISEASE 185 0.0257
144 PULSELESS ELECTRICAL ACTIVITY 107 0.0256
145 ESCHERICHIA BACTERAEMIA 60 0.0255
146 RENAL FAILURE ACUTE 1083 0.0255
147 ADENOVIRUS INFECTION 74 0.0255
148 HYPERNATRAEMIA 125 0.0251
149 HEPATOSPLENOMEGALY 64 0.0249
150 PNEUMOMEDIASTINUM 45 0.0249
151 TOXIC SKIN ERUPTION 249 0.0247
152 NOSOCOMIAL INFECTION 54 0.0245
153 CUTANEOUS VASCULITIS 89 0.0244
154 VENOOCCLUSIVE DISEASE 61 0.0243
155 CANDIDA INFECTION 411 0.0243
156 INFECTIOUS PLEURAL EFFUSION 37 0.0243
157 DERMATITIS EXFOLIATIVE 120 0.0240
158 ESCHERICHIA INFECTION 195 0.0237
159 SKIN NECROSIS 122 0.0235
160 BRAIN HERNIATION 70 0.0234
161 METABOLIC ENCEPHALOPATHY 70 0.0233
162 LUNG CONSOLIDATION 65 0.0232
163 DEVICE RELATED INFECTION 353 0.0229
164 HYPOALBUMINAEMIA 178 0.0229
165 STEVENS-JOHNSON SYNDROME 499 0.0224
166 ACUTE RESPIRATORY FAILURE 430 0.0223
167 ACIDOSIS 169 0.0221
168 ENCEPHALOPATHY 538 0.0219
169 GRAFT VERSUS HOST DISEASE IN SKIN 48 0.0218
170 CAPILLARY LEAK SYNDROME 45 0.0217
171 DERMATITIS BULLOUS 156 0.0215
172 RENAL INJURY 640 0.0215
173 TOXIC ENCEPHALOPATHY 109 0.0215
174 FEBRILE BONE MARROW APLASIA 91 0.0214
175 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 70 0.0212
176 ANURIA 181 0.0210
177 JUGULAR VEIN THROMBOSIS 37 0.0208
178 COMPLICATIONS OF TRANSPLANTED KIDNEY 47 0.0207
179 SHOCK 474 0.0206
180 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 102 0.0204
181 ARTHRITIS BACTERIAL 84 0.0204
182 DRUG ERUPTION 362 0.0204
183 METHAEMOGLOBINAEMIA 47 0.0203
184 HYPERSENSITIVITY VASCULITIS 53 0.0202
185 LUNG INFILTRATION 178 0.0201
186 RESPIRATORY FAILURE 1443 0.0198
187 DRUG LEVEL BELOW THERAPEUTIC 108 0.0196
188 END STAGE RENAL DISEASE 354 0.0194
189 INTRAVENTRICULAR HAEMORRHAGE 48 0.0193
190 ABSCESS LIMB 82 0.0192
191 CYTOMEGALOVIRUS COLITIS 44 0.0191
192 SEPSIS 2118 0.0190
193 DISTRIBUTIVE SHOCK 43 0.0190
194 WOUND DEHISCENCE 64 0.0189
195 HYPERCAPNIA 57 0.0189
196 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 52 0.0188
197 GLOMERULONEPHRITIS 46 0.0188
198 PULMONARY HAEMORRHAGE 146 0.0186
199 FEBRILE NEUTROPENIA 1237 0.0186
200 HYPOXIA 656 0.0186
201 CHOLESTATIC LIVER INJURY 41 0.0184
202 INFLAMMATORY MARKER INCREASED 91 0.0183
203 PANCYTOPENIA 1025 0.0183
204 ANHEDONIA 477 0.0181
205 ORGAN FAILURE 73 0.0181
206 RESPIRATORY ACIDOSIS 71 0.0180
207 FEAR 484 0.0180
208 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 106 0.0179
209 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 90 0.0178
210 PURPURA 157 0.0177
211 LIVEDO RETICULARIS 37 0.0177
212 HYPERBILIRUBINAEMIA 183 0.0176
213 MENTAL STATUS CHANGES 490 0.0176
214 DILATATION VENTRICULAR 37 0.0176
215 PROTHROMBIN TIME PROLONGED 105 0.0175
216 COAGULOPATHY 292 0.0175
217 AGRANULOCYTOSIS 321 0.0173
218 CANDIDIASIS 69 0.0172
219 CYTOLYTIC HEPATITIS 57 0.0172
220 BACTERIAL TEST POSITIVE 38 0.0170
221 AUTOIMMUNE HAEMOLYTIC ANAEMIA 58 0.0169
222 HAEMOTHORAX 49 0.0169
223 RENAL FAILURE 2238 0.0168
224 LUNG ABSCESS 35 0.0167
225 REBOUND ACID HYPERSECRETION 50 0.0165
226 NECROSIS 92 0.0165
227 AZOTAEMIA 66 0.0165
228 MENINGITIS 109 0.0163
229 AORTIC ARTERIOSCLEROSIS 42 0.0163
230 RENAL IMPAIRMENT 1359 0.0162
231 CYTOMEGALOVIRUS INFECTION REACTIVATION 71 0.0161
232 CHOLESTASIS 308 0.0160
233 BLOOD CREATININE INCREASED 1044 0.0160
234 NEUROTOXICITY 280 0.0160
235 OSTEOMYELITIS 289 0.0159
236 SINUS OPERATION 38 0.0159
237 NEPHROGENIC SYSTEMIC FIBROSIS 48 0.0159
238 RESPIRATORY DISTRESS 437 0.0158
239 HYPERTHERMIA 120 0.0157
240 PERIPHERAL ISCHAEMIA 64 0.0157
241 FIBROSIS 48 0.0156
242 FEAR OF DEATH 35 0.0156
243 ESCHERICHIA SEPSIS 45 0.0155
244 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 36 0.0155
245 STREPTOCOCCAL INFECTION 86 0.0154
246 PNEUMATOSIS INTESTINALIS 44 0.0154
247 RENAL FAILURE CHRONIC 118 0.0153
248 TACHYPNOEA 208 0.0153
249 VENTRICULAR HYPOKINESIA 49 0.0152
250 DIALYSIS 216 0.0152
251 EXFOLIATIVE RASH 40 0.0152
252 CYTOKINE RELEASE SYNDROME 304 0.0151
253 NEUROLOGICAL DECOMPENSATION 35 0.0151
254 METABOLIC ACIDOSIS 483 0.0151
255 HYPERAMMONAEMIA 75 0.0150
256 SERUM FERRITIN INCREASED 79 0.0150
257 MIXED LIVER INJURY 45 0.0149
258 GENERALISED OEDEMA 185 0.0149
259 ENCEPHALITIS 103 0.0149
260 IMMUNE THROMBOCYTOPENIC PURPURA 42 0.0148
261 CYTOMEGALOVIRUS INFECTION 246 0.0148
262 SHOCK HAEMORRHAGIC 120 0.0147
263 PULSE ABSENT 70 0.0147
264 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 139 0.0145
265 TORSADE DE POINTES 114 0.0145
266 CYTOMEGALOVIRUS VIRAEMIA 64 0.0144
267 PNEUMONIA BACTERIAL 132 0.0144
268 NEPHRITIS 48 0.0144
269 NEPHROPATHY 134 0.0143
270 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 785 0.0143
271 MUCOSAL INFLAMMATION 373 0.0142
272 THROMBOCYTOPENIA 1591 0.0142
273 THROMBOTIC THROMBOCYTOPENIC PURPURA 50 0.0142
274 HEPATOMEGALY 139 0.0141
275 HYPOVOLAEMIA 82 0.0140
276 ACUTE GRAFT VERSUS HOST DISEASE 64 0.0140
277 LEUKOPENIA 688 0.0137
278 ABDOMINAL INFECTION 35 0.0137
279 JAUNDICE CHOLESTATIC 48 0.0136
280 SCOLIOSIS 84 0.0135
281 EOSINOPHIL COUNT INCREASED 113 0.0135
282 ENTEROCOLITIS 78 0.0135
283 ABSCESS 215 0.0135
284 NEUTROPENIC SEPSIS 96 0.0134
285 TRANSAMINASES INCREASED 298 0.0134
286 CYSTITIS HAEMORRHAGIC 54 0.0134
287 STATUS EPILEPTICUS 151 0.0134
288 DRUG-INDUCED LIVER INJURY 416 0.0132
289 BLOOD UREA INCREASED 222 0.0132
290 SINUS TACHYCARDIA 188 0.0132
291 THROMBOTIC MICROANGIOPATHY 129 0.0132
292 URINE OUTPUT DECREASED 115 0.0131
293 ERYTHEMA MULTIFORME 122 0.0131
294 CACHEXIA 67 0.0130
295 CREATININE RENAL CLEARANCE DECREASED 52 0.0130
296 BACTERIAL INFECTION 242 0.0130
297 BRAIN DEATH 40 0.0129
298 BLOOD ALBUMIN DECREASED 102 0.0128
299 ENDOTRACHEAL INTUBATION 36 0.0128
300 HAEMOLYTIC ANAEMIA 115 0.0128
301 DECUBITUS ULCER 104 0.0127
302 HEPATIC NECROSIS 48 0.0127
303 INCORRECT DRUG ADMINISTRATION RATE 54 0.0127
304 HYDROCEPHALUS 69 0.0127
305 PLEURAL EFFUSION 767 0.0126
306 PNEUMONIA VIRAL 40 0.0125
307 HYPERVOLAEMIA 62 0.0125
308 BLOOD BILIRUBIN INCREASED 337 0.0125
309 HYPOKALAEMIA 574 0.0124
310 MALNUTRITION 139 0.0124
311 TUMOUR LYSIS SYNDROME 109 0.0124
312 PETECHIAE 129 0.0124
313 SEROTONIN SYNDROME 236 0.0123
314 INTESTINAL ISCHAEMIA 67 0.0122
315 FACE OEDEMA 205 0.0121
316 BLOOD LACTIC ACID INCREASED 64 0.0121
317 HEPATOCELLULAR INJURY 169 0.0119
318 RASH PUSTULAR 86 0.0118
319 PULMONARY ALVEOLAR HAEMORRHAGE 66 0.0118
320 BLOOD CREATINE INCREASED 52 0.0117
321 FAECAL CALPROTECTIN INCREASED 37 0.0117
322 VENTRICULAR TACHYCARDIA 192 0.0116
323 HYPERTRIGLYCERIDAEMIA 68 0.0116
324 FLUID OVERLOAD 169 0.0116
325 DRUG LEVEL DECREASED 118 0.0116
326 CARDIOGENIC SHOCK 166 0.0116
327 BK VIRUS INFECTION 39 0.0116
328 FAILURE TO THRIVE 60 0.0115
329 ISCHAEMIA 53 0.0115
330 BONE MARROW FAILURE 234 0.0115
331 PURULENT DISCHARGE 49 0.0115
332 BRONCHOSPASM 163 0.0114
333 HYPOPHOSPHATAEMIA 84 0.0114
334 EPSTEIN-BARR VIRUS INFECTION 71 0.0114
335 CELLULITIS 570 0.0113
336 ASCITES 332 0.0113
337 AORTIC VALVE INCOMPETENCE 48 0.0113
338 MYOCLONUS 134 0.0112
339 ELECTROLYTE IMBALANCE 130 0.0112
340 C-REACTIVE PROTEIN INCREASED 407 0.0112
341 HAEMOLYSIS 86 0.0111
342 MITRAL VALVE INCOMPETENCE 126 0.0111
343 PNEUMOTHORAX 174 0.0110
344 HERPES SIMPLEX 71 0.0109
345 HYPERPYREXIA 46 0.0109
346 ABDOMINAL ABSCESS 48 0.0108
347 BLOOD LACTATE DEHYDROGENASE INCREASED 172 0.0108
348 BLOOD ALKALINE PHOSPHATASE INCREASED 267 0.0107
349 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
350 DEAFNESS NEUROSENSORY 35 0.0106
351 HEPATITIS CHOLESTATIC 64 0.0106
352 ACUTE HEPATIC FAILURE 145 0.0106
353 ANAL ABSCESS 57 0.0106
354 CATHETER SITE INFECTION 40 0.0106
355 HYPOMAGNESAEMIA 147 0.0105
356 PYREXIA 3644 0.0105
357 EXTRAVASATION 43 0.0105
358 HEPATOTOXICITY 229 0.0103
359 THROMBOPHLEBITIS 36 0.0103
360 PNEUMOCYSTIS JIROVECII PNEUMONIA 103 0.0102
361 NEUTROPENIA 1387 0.0102
362 VENOUS THROMBOSIS 40 0.0102
363 ACUTE PULMONARY OEDEMA 57 0.0101
364 HEPATIC FAILURE 306 0.0101
365 INJURY 713 0.0101
366 ADRENAL INSUFFICIENCY 122 0.0100
367 BUNDLE BRANCH BLOCK RIGHT 46 0.0100
368 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
369 ALANINE AMINOTRANSFERASE INCREASED 611 0.0099
370 TRICUSPID VALVE INCOMPETENCE 79 0.0099
371 HYPERTRANSAMINASAEMIA 69 0.0099
372 ARTHRITIS INFECTIVE 46 0.0099
373 CEREBRAL ISCHAEMIA 51 0.0099
374 SUBCUTANEOUS ABSCESS 47 0.0098
375 MENINGITIS ASEPTIC 44 0.0098
376 RHINOVIRUS INFECTION 38 0.0098
377 ASPARTATE AMINOTRANSFERASE INCREASED 518 0.0097
378 CIRCULATORY COLLAPSE 166 0.0097
379 HYPOTENSION 1949 0.0097
380 RETINAL HAEMORRHAGE 69 0.0097
381 CARDIOMEGALY 119 0.0097
382 CARDIAC ARREST 795 0.0096
383 UNRESPONSIVE TO STIMULI 247 0.0096
384 GAMMA-GLUTAMYLTRANSFERASE INCREASED 212 0.0096
385 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 52 0.0095
386 CHOLANGITIS 59 0.0095
387 HYPERURICAEMIA 39 0.0095
388 ORGANISING PNEUMONIA 47 0.0095
389 POSTOPERATIVE WOUND INFECTION 64 0.0095
390 RASH ERYTHEMATOUS 451 0.0094
391 TACHYCARDIA 836 0.0094
392 ANAPHYLACTIC REACTION 516 0.0093
393 NEUROLOGICAL SYMPTOM 53 0.0093
394 THERAPY NON-RESPONDER 416 0.0092
395 ILEUS 115 0.0092
396 PERIORBITAL OEDEMA 48 0.0092
397 HYPERKALAEMIA 323 0.0092
398 VENTRICULAR FIBRILLATION 102 0.0092
399 PERITONITIS 190 0.0092
400 TREATMENT FAILURE 758 0.0091
401 RALES 53 0.0091
402 RASH GENERALISED 236 0.0091
403 TRANSPLANT REJECTION 73 0.0091
404 BRAIN OEDEMA 115 0.0091
405 ELECTROCARDIOGRAM QT PROLONGED 325 0.0090
406 ANAPHYLACTOID REACTION 37 0.0090
407 ILEUS PARALYTIC 40 0.0090
408 LACTIC ACIDOSIS 290 0.0089
409 HEPATIC FUNCTION ABNORMAL 331 0.0089
410 ACUTE MYELOID LEUKAEMIA 138 0.0088
411 VASCULITIS 103 0.0088
412 HEPATITIS 225 0.0088
413 HEPATIC CYTOLYSIS 112 0.0088
414 HYPOVOLAEMIC SHOCK 42 0.0088
415 COLITIS 332 0.0087
416 UROSEPSIS 79 0.0086
417 HEPATIC LESION 37 0.0085
418 COVID-19 PNEUMONIA 101 0.0085
419 PERITONITIS BACTERIAL 86 0.0085
420 LARGE INTESTINE PERFORATION 59 0.0085
421 FUNGAL INFECTION 282 0.0085
422 COLITIS ISCHAEMIC 57 0.0084
423 WOUND INFECTION 92 0.0084
424 ATRIAL FLUTTER 67 0.0084
425 CHRONIC KIDNEY DISEASE 637 0.0084
426 PAPULE 59 0.0084
427 CARDIO-RESPIRATORY ARREST 350 0.0084
428 SUPRAVENTRICULAR TACHYCARDIA 80 0.0083
429 WHITE BLOOD CELL COUNT INCREASED 320 0.0083
430 BREATH SOUNDS ABNORMAL 41 0.0083
431 BLOOD CREATINE PHOSPHOKINASE INCREASED 238 0.0083
432 DIVERTICULUM INTESTINAL 36 0.0082
433 CARDIAC MURMUR 71 0.0082
434 SPLENOMEGALY 96 0.0082
435 ECCHYMOSIS 56 0.0082
436 LYMPHOPENIA 115 0.0081
437 LIPASE INCREASED 62 0.0081
438 GENERALISED ERYTHEMA 46 0.0081
439 VENTRICULAR EXTRASYSTOLES 84 0.0081
440 RASH VESICULAR 39 0.0081
441 PERICARDIAL EFFUSION 186 0.0080
442 UNEVALUABLE EVENT 606 0.0080
443 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 41 0.0080
444 RESPIRATORY RATE INCREASED 71 0.0080
445 APNOEA 62 0.0080
446 DRUG INTERACTION 1263 0.0080
447 CHOLECYSTITIS 94 0.0079
448 JOINT EFFUSION 54 0.0078
449 HEPATIC ENCEPHALOPATHY 73 0.0078
450 IMMUNOSUPPRESSION 69 0.0078
451 PULMONARY OEDEMA 348 0.0078
452 NEUTROPHILIA 44 0.0077
453 FOETAL GROWTH RESTRICTION 47 0.0077
454 PULMONARY HYPERTENSION 161 0.0077
455 INTERNATIONAL NORMALISED RATIO INCREASED 220 0.0077
456 ODYNOPHAGIA 46 0.0077
457 HYPOTHERMIA 78 0.0077
458 LIVER INJURY 189 0.0077
459 REFUSAL OF TREATMENT BY PATIENT 50 0.0076
460 SINUS BRADYCARDIA 74 0.0076
461 NONSPECIFIC REACTION 42 0.0076
462 ABDOMINAL TENDERNESS 38 0.0076
463 ANAPHYLACTIC SHOCK 197 0.0076
464 HAEMORRHAGE INTRACRANIAL 114 0.0076
465 POST PROCEDURAL INFECTION 62 0.0076
466 CYSTIC FIBROSIS 42 0.0076
467 PLEURISY 45 0.0076
468 RHABDOMYOLYSIS 316 0.0076
469 PERIPHERAL VASCULAR DISORDER 39 0.0076
470 PNEUMONITIS 206 0.0076
471 BODY TEMPERATURE INCREASED 154 0.0075
472 TRANSFUSION 79 0.0075
473 ECONOMIC PROBLEM 114 0.0075
474 SPINAL OSTEOARTHRITIS 66 0.0075
475 MOUTH HAEMORRHAGE 55 0.0075
476 TROPONIN INCREASED 57 0.0075
477 PATHOLOGICAL FRACTURE 38 0.0075
478 LYMPHADENOPATHY 263 0.0074
479 CARDIOMYOPATHY 109 0.0074
480 UPPER GASTROINTESTINAL HAEMORRHAGE 124 0.0074
481 GANGRENE 44 0.0073
482 ORAL CANDIDIASIS 96 0.0073
483 SUBARACHNOID HAEMORRHAGE 74 0.0073
484 PARTIAL SEIZURES 38 0.0072
485 ALTERED STATE OF CONSCIOUSNESS 157 0.0072
486 OESOPHAGITIS 79 0.0072
487 CYTOPENIA 88 0.0072
488 MYOPATHY 62 0.0072
489 CARDIAC VALVE DISEASE 41 0.0072
490 GLOMERULAR FILTRATION RATE DECREASED 87 0.0071
491 CHOLECYSTITIS ACUTE 40 0.0071
492 HAEMOPTYSIS 196 0.0070
493 HEPATITIS ACUTE 45 0.0069
494 GINGIVITIS 37 0.0069
495 HYPOGAMMAGLOBULINAEMIA 45 0.0068
496 POLYURIA 56 0.0068
497 JAUNDICE 184 0.0068
498 ORAL DISORDER 50 0.0068
499 NO THERAPEUTIC RESPONSE 83 0.0068
500 PNEUMONIA ASPIRATION 170 0.0068
501 HYPONATRAEMIA 383 0.0068
502 RENAL CYST 54 0.0068
503 DELIRIUM 235 0.0068
504 GENERALISED TONIC-CLONIC SEIZURE 111 0.0067
505 RIGHT VENTRICULAR FAILURE 47 0.0067
506 HYDRONEPHROSIS 50 0.0067
507 HYPOCALCAEMIA 126 0.0067
508 HAEMATOCRIT DECREASED 132 0.0066
509 INTRACRANIAL PRESSURE INCREASED 37 0.0066
510 SKIN PLAQUE 56 0.0066
511 SKIN LESION 182 0.0066
512 NERVOUS SYSTEM DISORDER 205 0.0066
513 PROTEINURIA 124 0.0065
514 PLATELET COUNT DECREASED 694 0.0065
515 FISTULA 73 0.0065
516 DIFFUSE LARGE B-CELL LYMPHOMA 50 0.0065
517 CONDITION AGGRAVATED 1971 0.0065
518 ATRIAL FIBRILLATION 630 0.0065
519 ANAEMIA 1222 0.0064
520 POST PROCEDURAL COMPLICATION 123 0.0064
521 HYPERCALCAEMIA 79 0.0064
522 BRADYCARDIA 339 0.0064
523 ARTERIOSCLEROSIS 60 0.0064
524 EJECTION FRACTION DECREASED 99 0.0064
525 PULMONARY TOXICITY 45 0.0064
526 MYOSITIS 57 0.0063
527 TENDERNESS 66 0.0063
528 GASTROENTERITIS 92 0.0063
529 LOW BIRTH WEIGHT BABY 50 0.0063
530 PLATELET COUNT INCREASED 82 0.0063
531 RIB FRACTURE 129 0.0063
532 NEUTROPHIL COUNT DECREASED 255 0.0063
533 INTESTINAL PERFORATION 70 0.0062
534 HAEMATURIA 213 0.0062
535 DIARRHOEA HAEMORRHAGIC 58 0.0062
536 DIVERTICULUM 44 0.0062
537 CARDIAC FAILURE ACUTE 41 0.0061
538 GRANULOCYTOPENIA 35 0.0061
539 MELAENA 135 0.0061
540 LUNG INFECTION 95 0.0061
541 PANCREATITIS ACUTE 137 0.0061
542 DUODENAL ULCER 43 0.0061
543 LIVER FUNCTION TEST ABNORMAL 177 0.0061
544 OEDEMA 330 0.0061
545 GASTROINTESTINAL HAEMORRHAGE 507 0.0061
546 PNEUMONIA 1958 0.0060
547 CYANOSIS 95 0.0060
548 EMBOLISM 50 0.0060
549 SMALL INTESTINAL OBSTRUCTION 74 0.0060
550 HAEMATOMA 154 0.0059
551 OXYGEN SATURATION DECREASED 331 0.0059
552 BLOOD CALCIUM DECREASED 66 0.0059
553 DRUG TOXICITY 79 0.0058
554 INFUSION SITE EXTRAVASATION 36 0.0058
555 ENTERITIS 37 0.0058
556 WRONG PRODUCT ADMINISTERED 39 0.0058
557 PROCTALGIA 37 0.0057
558 UVEITIS 78 0.0057
559 RESPIRATORY SYNCYTIAL VIRUS INFECTION 50 0.0057
560 GENERAL PHYSICAL HEALTH DETERIORATION 656 0.0057
561 ASPIRATION 62 0.0057
562 ELECTROCARDIOGRAM ABNORMAL 44 0.0056
563 OSTEOPENIA 85 0.0056
564 MYOCARDITIS 64 0.0056
565 INFECTION 807 0.0056
566 PYELONEPHRITIS 48 0.0055
567 BLISTER 311 0.0055
568 PULMONARY CONGESTION 73 0.0055
569 DEPRESSED LEVEL OF CONSCIOUSNESS 219 0.0055
570 ACUTE MYOCARDIAL INFARCTION 163 0.0055
571 DISEASE PROGRESSION 651 0.0055
572 NEUTROPHIL COUNT INCREASED 56 0.0055
573 RASH PRURITIC 296 0.0055
574 BLOOD POTASSIUM INCREASED 88 0.0054
575 DEEP VEIN THROMBOSIS 352 0.0054
576 POST PROCEDURAL HAEMORRHAGE 63 0.0054
577 INTERVERTEBRAL DISC DEGENERATION 50 0.0054
578 NEUROLEPTIC MALIGNANT SYNDROME 64 0.0054
579 PROCEDURAL COMPLICATION 41 0.0053
580 MOUTH ULCERATION 112 0.0053
581 HAEMOGLOBIN DECREASED 544 0.0053
582 BRAIN INJURY 53 0.0053
583 POLYNEUROPATHY 63 0.0053
584 SKIN ULCER 136 0.0053
585 INFUSION RELATED REACTION 348 0.0052
586 HYPOPHAGIA 134 0.0052
587 CEREBRAL INFARCTION 128 0.0052
588 ATAXIA 62 0.0052
589 BLOOD SODIUM DECREASED 98 0.0052
590 EMPHYSEMA 52 0.0051
591 PSYCHIATRIC SYMPTOM 38 0.0051
592 BLOOD PRESSURE DIASTOLIC DECREASED 38 0.0051
593 COMA 245 0.0051
594 EYE INFLAMMATION 49 0.0051
595 HYPOTONIA 51 0.0051
596 BLOOD MAGNESIUM DECREASED 44 0.0051
597 LIVER FUNCTION TEST INCREASED 109 0.0051
598 CHILLS 594 0.0051
599 RESPIRATORY DEPRESSION 62 0.0051
600 APPENDICITIS 47 0.0050
601 HYPERLIPIDAEMIA 60 0.0050
602 DRUG INEFFECTIVE 6608 0.0050
603 PALLOR 136 0.0050
604 GRAND MAL CONVULSION 46 0.0050
605 PULMONARY MASS 74 0.0050
606 LETHARGY 285 0.0049
607 OFF LABEL USE 4327 0.0049
608 EMOTIONAL DISTRESS 594 0.0049
609 LOWER GASTROINTESTINAL HAEMORRHAGE 36 0.0049
610 DERMATITIS 102 0.0049
611 OBSTRUCTIVE AIRWAYS DISORDER 54 0.0048
612 CARDIOTOXICITY 43 0.0048
613 LYMPHOCYTE COUNT DECREASED 85 0.0048
614 LIVER DISORDER 213 0.0048
615 HYPERGLYCAEMIA 175 0.0048
616 PREMATURE DELIVERY 76 0.0048
617 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 42 0.0047
618 TOXICITY TO VARIOUS AGENTS 798 0.0047
619 ANGIOEDEMA 209 0.0047
620 WHITE BLOOD CELL COUNT DECREASED 507 0.0047
621 BLOOD POTASSIUM DECREASED 140 0.0047
622 SKIN HYPERPIGMENTATION 40 0.0047
623 CARDIAC FAILURE 373 0.0046
624 CEREBRAL HAEMORRHAGE 166 0.0046
625 RASH MACULAR 161 0.0046
626 BLOOD PRESSURE DECREASED 302 0.0045
627 OEDEMA PERIPHERAL 553 0.0045
628 DISEASE RECURRENCE 214 0.0045
629 HAEMATEMESIS 114 0.0045
630 HAEMATOCHEZIA 248 0.0045
631 FLANK PAIN 42 0.0045
632 SUBDURAL HAEMATOMA 64 0.0045
633 INTRAOCULAR PRESSURE INCREASED 57 0.0045
634 CHOLELITHIASIS 146 0.0044
635 PREMATURE BABY 133 0.0044
636 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 75 0.0044
637 WEIGHT FLUCTUATION 46 0.0044
638 ABNORMAL FAECES 36 0.0044
639 ERYTHEMA 898 0.0044
640 BLOOD DISORDER 35 0.0044
641 DISORIENTATION 172 0.0043
642 RASH 1884 0.0043
643 EYELID OEDEMA 50 0.0043
644 DERMATITIS ALLERGIC 54 0.0043
645 PERICARDITIS 72 0.0043
646 DEFORMITY 40 0.0043
647 HALLUCINATION, VISUAL 90 0.0043
648 HEPATIC STEATOSIS 79 0.0042
649 WHEEZING 250 0.0042
650 RESPIRATORY DISORDER 125 0.0042
651 DEAFNESS 109 0.0042
652 PRODUCT USE IN UNAPPROVED INDICATION 1033 0.0042
653 HYPERTENSIVE CRISIS 46 0.0041
654 LEUKAEMIA 39 0.0041
655 HEPATIC ENZYME INCREASED 281 0.0041
656 SPUTUM DISCOLOURED 39 0.0041
657 IMPAIRED HEALING 134 0.0041
658 RENAL DISORDER 190 0.0041
659 GASTRITIS 107 0.0041
660 JOINT RANGE OF MOTION DECREASED 54 0.0040
661 PRODUCT ADMINISTRATION ERROR 81 0.0040
662 COLITIS ULCERATIVE 179 0.0040
663 DEHYDRATION 531 0.0040
664 APHASIA 120 0.0040
665 VITREOUS FLOATERS 39 0.0040
666 MYOCARDIAL ISCHAEMIA 45 0.0040
667 ORAL HERPES 77 0.0039
668 VISUAL ACUITY REDUCED 131 0.0039
669 HIATUS HERNIA 51 0.0039
670 CONFUSIONAL STATE 633 0.0039
671 IRON DEFICIENCY ANAEMIA 36 0.0039
672 VITAMIN D DEFICIENCY 38 0.0039
673 REBOUND EFFECT 44 0.0039
674 LOCALISED INFECTION 94 0.0039
675 ABDOMINAL PAIN 904 0.0039
676 MASS 54 0.0039
677 HYPOGLYCAEMIA 187 0.0039
678 HAEMORRHOIDS 75 0.0038
679 PULMONARY EMBOLISM 365 0.0038
680 INFLAMMATION 198 0.0038
681 URINARY TRACT INFECTION 653 0.0038
682 INTERSTITIAL LUNG DISEASE 184 0.0038
683 INTERVERTEBRAL DISC PROTRUSION 83 0.0038
684 SCAR 65 0.0038
685 SKIN EXFOLIATION 320 0.0038
686 IMMUNODEFICIENCY 56 0.0038
687 MUSCULOSKELETAL CHEST PAIN 58 0.0037
688 SKIN INFECTION 42 0.0037
689 PAIN IN JAW 106 0.0037
690 ANXIETY 1061 0.0037
691 CHROMATURIA 84 0.0037
692 HEMIPARESIS 63 0.0037
693 EPILEPSY 113 0.0037
694 INCONTINENCE 39 0.0037
695 MUSCLE RIGIDITY 44 0.0037
696 CARDIAC FAILURE CONGESTIVE 295 0.0037
697 OSTEONECROSIS OF JAW 89 0.0036
698 RESPIRATORY ARREST 99 0.0036
699 THERAPY PARTIAL RESPONDER 56 0.0036
700 MYELOSUPPRESSION 129 0.0036
701 RED BLOOD CELL COUNT DECREASED 102 0.0036
702 FREQUENT BOWEL MOVEMENTS 96 0.0036
703 WOUND 99 0.0035
704 DYSPHAGIA 335 0.0035
705 PANCREATITIS 186 0.0035
706 TOOTH INFECTION 46 0.0035
707 LUNG DISORDER 171 0.0035
708 PRODUCT PRESCRIBING ISSUE 76 0.0035
709 RASH PAPULAR 78 0.0035
710 AGITATION 255 0.0035
711 HEPATIC CIRRHOSIS 65 0.0035
712 BONE DISORDER 63 0.0035
713 RECTAL HAEMORRHAGE 148 0.0034
714 EXPOSURE DURING PREGNANCY 214 0.0034
715 GASTRIC ULCER 65 0.0034
716 URTICARIA 569 0.0034
717 ULCER 54 0.0034
718 GLAUCOMA 65 0.0034
719 CONVULSION 193 0.0034
720 HEART RATE INCREASED 334 0.0034
721 DYSARTHRIA 126 0.0033
722 STOMATITIS 203 0.0033
723 LIP SWELLING 111 0.0033
724 LYMPHOMA 51 0.0033
725 ARRHYTHMIA 156 0.0033
726 TREATMENT NONCOMPLIANCE 180 0.0033
727 DIARRHOEA 2121 0.0033
728 PULMONARY FIBROSIS 63 0.0033
729 DENTAL CARIES 36 0.0033
730 PHARYNGITIS 40 0.0032
731 IMPAIRED QUALITY OF LIFE 46 0.0032
732 VIRAL INFECTION 106 0.0032
733 SEIZURE 366 0.0032
734 HYPOKINESIA 46 0.0032
735 NEUROPATHY PERIPHERAL 299 0.0031
736 MATERNAL EXPOSURE DURING PREGNANCY 280 0.0031
737 CONJUNCTIVITIS 58 0.0031
738 EPISTAXIS 232 0.0031
739 RESPIRATORY TRACT INFECTION 80 0.0031
740 SKIN REACTION 43 0.0030
741 BURSITIS 37 0.0030
742 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 159 0.0030
743 TOOTH LOSS 63 0.0030
744 PARALYSIS 43 0.0030
745 FAECES DISCOLOURED 65 0.0030
746 PRODUCTIVE COUGH 143 0.0030
747 HERPES ZOSTER 171 0.0030
748 HYPERSENSITIVITY 552 0.0030
749 TENDONITIS 46 0.0030
750 BLINDNESS 121 0.0030
751 OSTEOPOROSIS 122 0.0030
752 DYSPNOEA EXERTIONAL 111 0.0029
753 SKIN DISORDER 98 0.0029
754 URINARY RETENTION 98 0.0029
755 LOCAL SWELLING 51 0.0029
756 UPPER RESPIRATORY TRACT INFECTION 135 0.0029
757 HEART RATE IRREGULAR 66 0.0029
758 DYSPNOEA 1650 0.0029
759 ABDOMINAL DISTENSION 304 0.0029
760 PRURITUS 1117 0.0029
761 CORONARY ARTERY DISEASE 88 0.0029
762 LOWER RESPIRATORY TRACT INFECTION 132 0.0029
763 METASTASES TO LIVER 51 0.0029
764 SWELLING FACE 187 0.0029
765 PRURITUS GENERALISED 61 0.0028
766 DIVERTICULITIS 78 0.0028
767 VOMITING 1323 0.0028
768 OSTEOARTHRITIS 119 0.0028
769 INFUSION SITE PAIN 36 0.0028
770 ORAL PAIN 62 0.0028
771 HYPERTENSION 582 0.0027
772 ISCHAEMIC STROKE 49 0.0027
773 HAEMORRHAGE 287 0.0027
774 METASTASES TO BONE 45 0.0027
775 MUSCLE TWITCHING 63 0.0027
776 MYDRIASIS 35 0.0027
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 194 0.0027
778 LABORATORY TEST ABNORMAL 80 0.0027
779 RESPIRATORY TRACT CONGESTION 43 0.0027
780 MYELODYSPLASTIC SYNDROME 39 0.0027
781 HYPOTHYROIDISM 85 0.0027
782 GASTROOESOPHAGEAL REFLUX DISEASE 212 0.0026
783 SINUS DISORDER 52 0.0026
784 QUALITY OF LIFE DECREASED 35 0.0026
785 PHOTOPHOBIA 49 0.0026
786 MENTAL IMPAIRMENT 63 0.0026
787 BONE LOSS 39 0.0026
788 DISABILITY 51 0.0026
789 BLOOD PRESSURE SYSTOLIC INCREASED 50 0.0026
790 GOUT 46 0.0026
791 KIDNEY INFECTION 50 0.0025
792 INTENTIONAL PRODUCT USE ISSUE 222 0.0025
793 CHEST PAIN 467 0.0025
794 URINARY INCONTINENCE 74 0.0025
795 HEART RATE DECREASED 87 0.0025
796 SWOLLEN TONGUE 77 0.0025
797 FLUSHING 249 0.0024
798 PAIN 1488 0.0024
799 HYPOACUSIS 104 0.0024
800 FOETAL EXPOSURE DURING PREGNANCY 196 0.0024
801 EYE PAIN 136 0.0024
802 SYNCOPE 241 0.0024
803 DRUG INTOLERANCE 231 0.0024
804 DYSURIA 88 0.0024
805 ASTHENIA 890 0.0024
806 HALLUCINATION 178 0.0024
807 CYSTITIS 75 0.0024
808 COUGH 655 0.0023
809 PRESCRIBED OVERDOSE 45 0.0023
810 PLASMA CELL MYELOMA 90 0.0023
811 NEPHROLITHIASIS 105 0.0023
812 INTESTINAL OBSTRUCTION 86 0.0023
813 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
814 OBESITY 36 0.0023
815 SINUSITIS 231 0.0023
816 BLOOD PRESSURE FLUCTUATION 54 0.0022
817 ACCIDENTAL OVERDOSE 82 0.0022
818 ORTHOSTATIC HYPOTENSION 39 0.0022
819 TYPE 2 DIABETES MELLITUS 75 0.0022
820 TOOTHACHE 40 0.0022
821 ANGINA PECTORIS 63 0.0022
822 SKIN DISCOLOURATION 101 0.0022
823 LOSS OF CONSCIOUSNESS 281 0.0022
824 OSTEONECROSIS 72 0.0022
825 GALLBLADDER DISORDER 39 0.0022
826 NEURALGIA 53 0.0022
827 THERAPEUTIC RESPONSE DECREASED 132 0.0022
828 SEDATION 57 0.0022
829 GASTROINTESTINAL DISORDER 194 0.0022
830 MEDICATION ERROR 120 0.0022
831 WEIGHT DECREASED 601 0.0022
832 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
833 SLEEP APNOEA SYNDROME 41 0.0021
834 DEPRESSION 488 0.0021
835 BLOOD PRESSURE INCREASED 324 0.0021
836 AGGRESSION 106 0.0021
837 HYPERHIDROSIS 272 0.0021
838 TREMOR 349 0.0021
839 SWELLING 195 0.0021
840 BRONCHITIS 153 0.0021
841 PRODUCT USE ISSUE 388 0.0021
842 RETCHING 44 0.0021
843 FOOT FRACTURE 39 0.0021
844 MALIGNANT NEOPLASM PROGRESSION 209 0.0020
845 DECREASED APPETITE 471 0.0020
846 NAUSEA 1592 0.0020
847 BONE DENSITY DECREASED 63 0.0020
848 BACK PAIN 463 0.0020
849 RESTLESSNESS 72 0.0020
850 EAR INFECTION 52 0.0020
851 THROAT TIGHTNESS 52 0.0019
852 COVID-19 337 0.0019
853 INFLUENZA 214 0.0019
854 ASTHMA 216 0.0019
855 UPPER LIMB FRACTURE 38 0.0019
856 LIMB DISCOMFORT 59 0.0019
857 JOINT STIFFNESS 50 0.0019
858 EAR PAIN 37 0.0019
859 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 55 0.0019
860 THROMBOSIS 151 0.0019
861 SPEECH DISORDER 98 0.0019
862 DIABETES MELLITUS 142 0.0019
863 TINNITUS 85 0.0018
864 CEREBROVASCULAR ACCIDENT 310 0.0018
865 PALPITATIONS 213 0.0018
866 SOMNOLENCE 366 0.0018
867 NIGHT SWEATS 58 0.0018
868 DIABETIC KETOACIDOSIS 43 0.0018
869 NASAL CONGESTION 105 0.0018
870 MUSCULOSKELETAL PAIN 93 0.0018
871 OROPHARYNGEAL PAIN 163 0.0018
872 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 41 0.0018
873 SYSTEMIC LUPUS ERYTHEMATOSUS 62 0.0017
874 FEELING HOT 107 0.0017
875 ILLNESS 178 0.0017
876 DEMENTIA 48 0.0017
877 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
878 MUSCULAR WEAKNESS 194 0.0017
879 ABASIA 42 0.0017
880 FLUID RETENTION 86 0.0017
881 PRESYNCOPE 41 0.0017
882 DRUG ADMINISTRATION ERROR 51 0.0017
883 PRODUCT DISPENSING ERROR 36 0.0017
884 MYALGIA 280 0.0016
885 RHINORRHOEA 105 0.0016
886 DYSKINESIA 66 0.0016
887 CHEST DISCOMFORT 164 0.0016
888 PERIPHERAL SWELLING 246 0.0016
889 NECK PAIN 89 0.0016
890 MYOCARDIAL INFARCTION 277 0.0016
891 CONTUSION 152 0.0016
892 BURNING SENSATION 109 0.0016
893 MALAISE 680 0.0015
894 AMNESIA 100 0.0015
895 ADVERSE DRUG REACTION 137 0.0015
896 DISCOMFORT 93 0.0015
897 FLATULENCE 86 0.0015
898 ECZEMA 79 0.0015
899 WEIGHT INCREASED 337 0.0015
900 DEATH 1273 0.0015
901 FALL 486 0.0015
902 PAIN IN EXTREMITY 425 0.0014
903 BONE PAIN 84 0.0014
904 CONSTIPATION 311 0.0014
905 ABDOMINAL PAIN UPPER 290 0.0014
906 MENTAL DISORDER 61 0.0014
907 PARAESTHESIA 220 0.0014
908 GAIT DISTURBANCE 267 0.0014
909 DYSPHONIA 81 0.0014
910 ABDOMINAL PAIN LOWER 35 0.0014
911 COGNITIVE DISORDER 64 0.0014
912 PROCEDURAL PAIN 38 0.0014
913 JOINT SWELLING 164 0.0014
914 CARDIAC DISORDER 127 0.0014
915 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
916 OCULAR HYPERAEMIA 63 0.0013
917 LIMB INJURY 36 0.0013
918 THERAPY CESSATION 68 0.0013
919 ARTHRITIS 103 0.0013
920 HIP FRACTURE 42 0.0013
921 DYSSTASIA 38 0.0013
922 HYPOAESTHESIA 194 0.0013
923 MOBILITY DECREASED 92 0.0013
924 VERTIGO 78 0.0013
925 VISUAL IMPAIRMENT 156 0.0013
926 PSYCHOTIC DISORDER 37 0.0013
927 OVERDOSE 269 0.0012
928 CATARACT 74 0.0012
929 NERVOUSNESS 64 0.0012
930 FATIGUE 947 0.0012
931 ARTHRALGIA 505 0.0012
932 IRRITABILITY 73 0.0012
933 NEOPLASM PROGRESSION 42 0.0012
934 HOSPITALISATION 181 0.0012
935 HEAD INJURY 37 0.0012
936 EMOTIONAL DISORDER 36 0.0012
937 DISTURBANCE IN ATTENTION 61 0.0011
938 MUSCULOSKELETAL STIFFNESS 99 0.0011
939 POLLAKIURIA 47 0.0011
940 HEADACHE 706 0.0011
941 EYE DISORDER 37 0.0011
942 BLOOD GLUCOSE DECREASED 54 0.0011
943 EYE SWELLING 41 0.0011
944 DIZZINESS 546 0.0011
945 THROAT IRRITATION 49 0.0011
946 ABNORMAL BEHAVIOUR 43 0.0011
947 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 194 0.0011
948 ROAD TRAFFIC ACCIDENT 45 0.0011
949 BALANCE DISORDER 92 0.0011
950 INCORRECT ROUTE OF DRUG ADMINISTRATION 38 0.0011
951 DYSPEPSIA 101 0.0010
952 NO ADVERSE EVENT 185 0.0010
953 ILL-DEFINED DISORDER 62 0.0010
954 NASOPHARYNGITIS 184 0.0010
955 INSOMNIA 261 0.0010
956 VISION BLURRED 132 0.0010
957 SLEEP DISORDER 67 0.0009
958 ABDOMINAL DISCOMFORT 159 0.0009
959 SURGERY 55 0.0009
960 DYSGEUSIA 69 0.0009
961 INFLUENZA LIKE ILLNESS 76 0.0009
962 DRY EYE 46 0.0009
963 INTENTIONAL PRODUCT MISUSE 79 0.0009
964 BLOOD GLUCOSE INCREASED 169 0.0009
965 ARTHROPATHY 49 0.0009
966 MUSCLE SPASMS 153 0.0008
967 WITHDRAWAL SYNDROME 35 0.0008
968 MIGRAINE 78 0.0008
969 DRUG EFFECT DECREASED 44 0.0008
970 DRY MOUTH 65 0.0008
971 DRUG WITHDRAWAL SYNDROME 69 0.0008
972 INCORRECT DOSE ADMINISTERED 178 0.0008
973 ADVERSE EVENT 69 0.0007
974 THERAPY INTERRUPTED 52 0.0007
975 ALOPECIA 142 0.0007
976 RHEUMATOID ARTHRITIS 82 0.0007
977 FEELING ABNORMAL 171 0.0007
978 SUICIDAL IDEATION 65 0.0007
979 NEOPLASM MALIGNANT 47 0.0007
980 MEMORY IMPAIRMENT 94 0.0007
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45 0.0006
982 INTENTIONAL OVERDOSE 36 0.0006
983 DRY SKIN 73 0.0005
984 UNDERDOSE 39 0.0005
985 HOT FLUSH 40 0.0005
986 DEVICE MALFUNCTION 36 0.0005
987 PRODUCT STORAGE ERROR 38 0.0004
988 PRODUCT QUALITY ISSUE 56 0.0004
989 PSORIASIS 51 0.0004
990 PRODUCT DOSE OMISSION ISSUE 114 0.0004
991 INJECTION SITE ERYTHEMA 41 0.0003
992 DRUG DOSE OMISSION 52 0.0003
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
994 INJECTION SITE PAIN 67 0.0002